About the College
Admissions
Doctor of Pharmacy
Graduate Programs
Academic Divisions
Service Divisions
Alumni and Friends
 

Calendar
News
Employment
Contact Us
U of Iowa

For Preceptors
Faculty/Staff Login
Giving To The College
Diversity & The College
Continuing Education

  Purple Square- About the College Red Square- Admissions Green Square - Doctor of Pharmacy Orange Square- Graduate Programs Blue Square- Academic Divisions service divisions brown bar Yellow Square- Alumni and Friends
     

2007 annual report

     
    FROM THE DEAN
   
   
   
   
   
LAYING THE FOUNDATION
   
     
   
ACADEMIC DIVISIONS
     
     
     
   
   
   
   

This Web site features an edited version of the 2007 College of Pharmacy Annual Report. For a copy of the full report, which includes the University's Financial Statement, & Honor Roll, please e-mail a request to the publications coordinator.

 

 

 
class of 2007

COLLEGE OF PHARMACY GRANTS
John M Brooks co-investigator, (Robert Wallace, PI), Lung Cancer Care Outcomes/Surveillance Consortium- Iowa, NIH, $99,997.

John M Brooks co-investigator, (Peter Cram, PI), Cardiac Care in Specialty and General Hospitals, NIH, $698,739.

Barry L Carter, PI, with co-investigators Karen B Farris and Paul Abramowitz, Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases, NIH, $712,646.

Barry L Carter, IPA Agreement – Dr. Kaboli’s VA Grant IMV 04-066, Implementing Evidence Based Treatment of Hypertension, US Department of Veterans Affair, $8,642.

Barry L Carter, IPA Agreement – Dr. Rosenthal’s VA Grant HFP 04-149, Center for the Research in the Implementation of Innovative Strategies in Practice (CRIISP), US Department of Veterans Affair, $17,291.

Barry L Carter, PI, with co-investigators Elizabeth A Chrischilles and William R Doucette, Improving Adherence to Blood Pressure Guidelines, NIH, $615,123.

Elizabeth A Chrischilles co-investigator (Fredric Wolinsky, PI), Health and Health Services Use in the HRS/AHEAD, NIH, $355,619.

Elizabeth A Chrischilles, PI, with co-investigators John M Brooks, Barry L Carter, William R Doucette, Karen B Farris, and Julie M Urmie, University of Iowa Older Adults CERT, NIH, $799,999.

Elizabeth A Chrischilles co-investigator, (David Lubaroff, PI), Prostate Cancer Research Training Program, US Department of Defense, Army, $199,446.

Elizabeth A Chrischilles, PI, with co-investigators William R Doucette and Karen B Farris, Pharmaceutical Case Management and Living Well with a Disability, US Department of Health & Human Services, Centers for Disease Control & Prevention, $324,999.

Elizabeth A Chrischilles co-investigator, (James Merchant, PI), Healthier Workforce Center for Excellence, US Department of Health & Human Services, Centers for Disease Control & Prevention, $1,000,000.

Elizabeth A Chrischilles co-investigator, (Robert Wallace, PI),Integrating Aging and Cancer Research, NIH, $610,600.

Elizabeth A Chrischilles co-investigator, (Peter Thorne, PI), Environmental Health Sciences Research Center, NIH, $1,607,561.

Maureen D Donovan, Bypassing the Blood Brain Barrier: Modulation of Transporters in the Nasal Mucosa, NIH, $295,422.

Jonathan A Doorn, Protein Modification by 3,4- dihydroxyphenylacetaldehyde, NIH, $100,158.

Jonathan A Doorn, Kevin G Rice, and Thomas E Prisinzano, co-investigators, (James Gloer, PI), Acquisition of a Q-TOF Mass Spectrometer, NIH, $487,380.

William R Doucette, PI, with co-investigators Karen B Farris, Randall McDonough, Elizabeth A Chrischilles and James D Hoehns, An Initial Evaluation of Medication Therapy Management (MTM) Services in the Upper Midwest, Community Pharmacy Foundation, $93,700.

William R Doucette, PI, with co-investigators Karen B Farris and Randall McDonough, Community Pharmacy Foundation, $59,838.

Michael W Duffel, project director (Larry Robertson, program PI), Semi-Volatile PCBs: Sources, Exposures, Toxicities, NIH, $2,962,053.

Michael W Duffel, Aryl and Alcohol Sulfotransferases in Drug Metabolism, NIH, $227,666.

Lawrence L Fleckenstein, Safe Pregnancy by Infectious Disease Control in Kinshasa, University of North Carolina, $62,575.

Lawrence L Fleckenstein, Moxidectin HPLC Analysis in Plasma and Pharmacokinetic Evaluation, World Health Organization, $62,407.

Lawrence L Fleckenstein, Wyeth Pharmaceuticals Clinical Consulting Services Agreement, Wyeth Pharmaceuticals, Inc., $20,000.

Robert J Kerns, Lethal Action of Fluoroquinolones with Non-Growing Mycobacterium Tuberculosis, Public Health Research Institute, $89,750.

Robert J Kerns, Saccharide-Based Effectors of Cationic Antimicrobial Peptides, NIH, $184,375.

Bradley G Phillips co-investigator (Francois Abboud, PI), Program Project Grant: Integrative Neurobiology of Cardiovascular Regulation, NIH, $2,278,026.

Rolland I Poust, Manufacturing of Oral and Topical Dosage Forms, NIH, $284,041.

Kevin G Rice, Proteasome Inhibitor Enhanced Non-Viral Gene Delivery, NIH, $45,713.

Kevin G Rice, Proteasome Inhibitor Enhanced Non-Viral Gene Delivery, NIH, $253,979.

Vicki Ellingrod Ringold co-investigator, (Leigh Beglinger, PI), Cognition in Clinical Trials for Huntington’s Disease, NIH, $152,025.

Julie M Urmie, PI, and co-investigator John M Brooks, Effect of a Restrictive Formulary on Low Income Children, Agency for Healthcare Research & Quality, $94,780.

Peter Veng-Pedersen, project director, (John A Widness, program PI), Neonatal Anemia: Pathophysiology and Treatment/Optimized Erythropoietin Treatment of Neonatal Anemia, NIH, $1,910,068.

Peter Veng-Pedersen, PI, Comparison of the In-Vivo Epo Receptor Binding Properties of CERA and rHuEpo in the Bone Marrow and Their Binding Outside the Bone Marrow, Roche, Penzberg, Germany, $99,145.

 

 
     
     
University of Iowa